Your browser doesn't support javascript.
loading
Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review.
Van den Broeck, Thomas; van den Bergh, Roderick C N; Arfi, Nicolas; Gross, Tobias; Moris, Lisa; Briers, Erik; Cumberbatch, Marcus; De Santis, Maria; Tilki, Derya; Fanti, Stefano; Fossati, Nicola; Gillessen, Silke; Grummet, Jeremy P; Henry, Ann M; Lardas, Michael; Liew, Matthew; Rouvière, Olivier; Pecanka, Jakub; Mason, Malcolm D; Schoots, Ivo G; van Der Kwast, Theo H; van Der Poel, Henk G; Wiegel, Thomas; Willemse, Peter-Paul M; Yuan, Yuhong; Lam, Thomas B; Cornford, Philip; Mottet, Nicolas.
Afiliación
  • Van den Broeck T; Department of Urology, University Hospitals Leuven, Leuven, Belgium; Laboratory of Molecular Endocrinology, KU Leuven, Leuven, Belgium. Electronic address: vandenbroeck.thomas@gmail.com.
  • van den Bergh RCN; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Arfi N; Department of Urology, Hospital Saint Luc Saint Joseph, Lyon, France.
  • Gross T; Department of Urology, University of Bern, Inselspital, Bern, Switzerland.
  • Moris L; Department of Urology, University Hospitals Leuven, Leuven, Belgium; Laboratory of Molecular Endocrinology, KU Leuven, Leuven, Belgium.
  • Briers E; Hasselt, Belgium.
  • Cumberbatch M; Academic Urology Unit, University of Sheffield, Sheffield, UK.
  • De Santis M; Charite Universitätsmedizin, Berlin, Germany; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Tilki D; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Fanti S; Nuclear Medicine Division, Policlinico S. Orsola, University of Bologna, Italy.
  • Fossati N; Unit of Urology/Division of Oncology, URI, IRCCS Ospedale San Raffaele, Milan, Italy; Università Vita-Salute San Raffaele, Milan, Italy.
  • Gillessen S; Division of Cancer Sciences, University of Manchester and The Christie, Manchester, UK; Department of Oncology and Haematology, Cantonal Hospital St Gallen, St Gallen, Switzerland; University of Bern, Bern, Switzerland.
  • Grummet JP; Department of Surgery, Central Clinical School, Monash University, Caulfield North, Victoria, Australia.
  • Henry AM; Leeds Cancer Centre, St. James's University Hospital and University of Leeds, Leeds, UK.
  • Lardas M; Department of Urology, Leto Hospital, Athens, Greece.
  • Liew M; Department of Urology, Wrightington, Wigan and Leigh NHS Foundation Trust, Wigan, UK.
  • Rouvière O; Hospices Civils de Lyon, Radiology Department, Edouard Herriot Hospital, Lyon, France.
  • Pecanka J; Pecanka Consulting Services, Prague, Czech Republic; Department of Biomedical Data Sciences, University Medical Center, Leiden, The Netherlands.
  • Mason MD; Division of Cancer & Genetics, School of Medicine Cardiff University, Velindre Cancer Centre, Cardiff, UK.
  • Schoots IG; Department of Radiology & Nuclear Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
  • van Der Kwast TH; Department of Pathology, Erasmus Medical Centre, Rotterdam, The Netherlands.
  • van Der Poel HG; Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Wiegel T; Department of Radiation Oncology, University Hospital Ulm, Ulm, Germany.
  • Willemse PM; Department of Urology, University Hospital Groningen, Groningen, The Netherlands.
  • Yuan Y; Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • Lam TB; Academic Urology Unit, University of Aberdeen, Aberdeen, UK; Department of Urology, Aberdeen Royal Infirmary, Aberdeen, UK.
  • Cornford P; Royal Liverpool and Broadgreen Hospitals NHS Trust, Liverpool, UK.
  • Mottet N; Department of Urology, University Hospital, St. Etienne, France.
Eur Urol ; 75(6): 967-987, 2019 06.
Article en En | MEDLINE | ID: mdl-30342843
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Calicreínas / Antígeno Prostático Específico / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans / Male Idioma: En Revista: Eur Urol Año: 2019 Tipo del documento: Article Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Calicreínas / Antígeno Prostático Específico / Recurrencia Local de Neoplasia Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Límite: Humans / Male Idioma: En Revista: Eur Urol Año: 2019 Tipo del documento: Article Pais de publicación: Suiza